Jerath Nivedita U
AdventHealth Neuroscience Institute, 1573 West Fairbanks Avenue, Suite 210 Winter Park, Orlando, FL, USA.
Case Rep Med. 2022 May 24;2022:7492077. doi: 10.1155/2022/7492077. eCollection 2022.
This study presents the clinical and electrophysiological findings of four subjects with a pathogenic heterozygous GDAP1 variant causing Charcot-Marie-Tooth disease 2K (CMT2K) and one additional subject with an uncertain GDAP1 variant and clinical findings of CMT 2K. The study evaluated these five subjects using clinical, laboratory, electrophysiological, and genetic testing. The findings showed that clinical features demonstrated no pes cavus, no significant weakness in the hands or feet, normal reflexes in four out of the five subjects, and mild to normal electrodiagnostic findings. The variant was associated with painful and numb feet with diminished sensation to pinprick. This study suggests that GDAP1 variants may be associated with very mild, predominantly sensory Charcot-Marie-Tooth disease, warranting continuing research for this type of the disease.
本研究报告了4例携带致病性杂合GDAP1变异导致2K型夏科-马里-图思病(CMT2K)患者以及1例携带不确定GDAP1变异且有CMT2K临床表现患者的临床和电生理检查结果。该研究通过临床、实验室、电生理和基因检测对这5名受试者进行了评估。结果显示,临床特征表现为无高弓足,手足无明显无力,5名受试者中有4名反射正常,电诊断结果为轻度至正常。该变异与足部疼痛、麻木以及针刺觉减退有关。本研究表明,GDAP1变异可能与非常轻微的、以感觉为主的夏科-马里-图思病有关,值得对这类疾病继续开展研究。